Nanotechnology enabled long-acting antiretroviral therapy for improved HIV treatment adherence (ACH4 grant administered by the Westmead Institute for Medical Research) (2023–2024)
- Grant type:
- Australian Centre for HIV and Hepatitis Virology Research (ACH4)
- Researchers:
-
-
ARC DECRA NHMRC Emerging Leadership
Australian Institute for Bioengineering and Nanotechnology
-
- Funded by:
- The Westmead Institute for Medical Research
